The company of Bullfrog AI is a Maryland-based that is technology-enabled drug-development firm. The company works with an AI platform that biopharmaceutical companies use. These biopharmaceutical companies use Bullfrog AI in clinical developmental programs of the drugs. Especially, the main goal of Bullfrog AI is to be the future of AI-assisted drug development. They stated their mission is to discover the connections among therapies and patients to improve their lives.
Thus, Bullfrog AI company will use machine learning to perform medical breakthroughs. In addition to this, there is no doubt that it will help to save millions of lives by Artificial Intelligence.
What is Bullfrog AI?
Bullfrog AI is an upcoming drug discovery firm. It is a next-generation drug discovery firm. The company works by using Artificial Intelligence to get maximum benefit as it works by performing the guesswork out of a very time-consuming research process. Thus, it perfectly assists in accelerating the knowledge of experts in medicine.
We can say that this generative AI plays a significant role in creating and analyzing. Basically, the AI firm creates and analyzes the networks of biological, clinical, and real-world data spanning from early discovery to late-stage clinical trials. The company performs all the tasks by utilizing a proprietary platform named BfLEAP. The bfLEAP works by leveraging the power of AI and machine learning so that it digests or analyzes a large amount of disparate data. Moreover, the company also revealed that it may lead to identifying new potential therapeutic targets, indication expansion opportunities for existing products, and drug rescuing or repurposing.
Company’s Product:
The basic platform of the company is bfLEAP. It is the prediction tool for now that will work as a clinical tool. The platform of bfLEAP operates in five specific steps that are:
- Ingesting of the data
- Data exploration or cleansing
- Analyzing the field and distributions
- Correlation analysis
- Building the models
The bfLEAP aims to be used for the last-stage drug candidates. It will analyze all the previous clinical trial databases to check how a patient will respond to different therapies. Moreover, this technology will also discover novel drug targets. After this, it will find the niche patient populations where a specific drug target benefits the patients effectively. Then, it will find out about the combination of different drugs to facilitate the patients with synergetic effects.
The owner of Bullfrog AI:
Bullfrog AI is a publicly made business in the US. The company doesn’t have any parent company. The company of Bullfrog AI is led by Vin Singh, who was the CEO of the company in the year 2017. Bullfrog AI has a senior leadership team including Enrique García-Rivera, Ph.D., VP of AI along with Thomas Hazel, Ph.D., VP of Drug Development.
Bullfrog AI aims to change the working of drug development:
We all know how risky is the industry of drug development, and how slow its working is. The period of drug development is very long and it is very risky for the patients also. The process of drug development is inefficient. Moreover, developing a new product normally consumes a large time of approximately a decade. The processes typically are very costly and the patients who are suffering from a certain disease are desperately waiting for their treatment.But, the saddest part is that after a lot of effort, the process of drug development ends up failing. Thus, the company of Bullfrog aims to minimize the risk to a great extent. The recent survey of this company about the drug developments includes:
- Average time in a market – 8.5 years
- Total annual R&D spending by 2024, 3% CAGR – $204 Billion
- The cost of bringing a drug to market – $0.8 to $2.8 Billion
- Almost 90% of drugs can’t even succeed
Experts of drug development:
The company of Bullfrog AI claims that they are working with the Drug Developmental Expertise that will efficiently drive this program forward. They believe that they can elevate maximum risk in their journey. Regarding the Drug Developmental Expertise, they claimed that; “Our high-performing team of AI and drug development experts are industry leaders who are determined to revolutionize the industry using next-generation analytics”.
They also discussed their positive aim to move forward in this field and work efficiently and smoothly to eliminate the risks. They said: “Our goal is to disrupt the future of drug development by improving speed and accuracy in all phases of the process.”
COVID-19:
The company Bullfrog AI was even used in the time of the COVID-19 pandemic. The amazing technology was used when they affiliated with EastBanc Technologies. Which they also streamlined the process of finding therapies for treating patients with this virus.
Can Bullfrog AI be a thriving future for humankind:
Currently, many pharmaceutical firms are present in the markets that are utilizing Artificial Intelligence. The companies have witnessed effective results in their medical research. So, we can rely on AI for better or instant results.
Three years ago, The United States National Library of Medicine published research that explains how “the use of artificial intelligence (AI) has been increasing in the pharmaceutical industry”. Even Recently, scientists from the Agency for Science, Technology and Research (A*STAR) Genome Institute of Singapore (GIS) showed an RNA sequencing tool named Bambu. This tool can tell us more about our DNA. Thus. artificial intelligence has significantly increased the painstakingly time-consuming process in the service of improving our lives as humans.
Stock Performance of Bullfrog AI:
| Stock Price: | $7.37 |
| Previous Close: | $6.84 |
| 52 wk Range: | $2.36 – $9.50 |
| Market Cup: | $45.1M |
| Shares: | 6.09M |
| Average Volume: | 2.42M |
| EPS: | -$0.84 |
